335 related articles for article (PubMed ID: 31390578)
21. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
22. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma.
Wang S; Li Y; Lin Y; Li J; Guo L; Wang H; Lin X; Liu Z; Zhang B; Liao Z; Zhang Z
Sci Rep; 2024 May; 14(1):11985. PubMed ID: 38796629
[TBL] [Abstract][Full Text] [Related]
25. The role of
Ma Z; Qi Z; Shan Z; Li J; Yang J; Xu Z
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28923830
[TBL] [Abstract][Full Text] [Related]
26. Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Jun; 36(6):e24409. PubMed ID: 35441741
[TBL] [Abstract][Full Text] [Related]
27. Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Wang H; Huang L; Chen L; Ji J; Zheng Y; Wang Z
Comput Math Methods Med; 2021; 2021():9059116. PubMed ID: 34659450
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
[TBL] [Abstract][Full Text] [Related]
29. Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
Park J; Lee EH; Sim H; Na AY; Choi SY; Chung JW; Ha YS; Kwon TG; Lee S; Lee JN
Cancer Genomics Proteomics; 2023; 20(6):592-601. PubMed ID: 37889066
[TBL] [Abstract][Full Text] [Related]
30. Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.
Zhang JJ; Hong J; Ma YS; Shi Y; Zhang DD; Yang XL; Jia CY; Yin YZ; Jiang GX; Fu D; Yu F
Dis Markers; 2021; 2021():6696198. PubMed ID: 33505535
[TBL] [Abstract][Full Text] [Related]
31. FN1 and cancer-associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma.
Ashok G; Ramaiah S
J Gene Med; 2023 Dec; 25(12):e3556. PubMed ID: 37358013
[TBL] [Abstract][Full Text] [Related]
32. Identification of Inflammation-Related Biomarker Pro-ADM for Male Patients With Gout by Comprehensive Analysis.
Qiu K; Zeng T; Liao Y; Min J; Zhang N; Peng M; Kong W; Chen LL
Front Immunol; 2021; 12():798719. PubMed ID: 35116032
[TBL] [Abstract][Full Text] [Related]
33. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico.
Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y
Hereditas; 2019; 156():20. PubMed ID: 31285741
[TBL] [Abstract][Full Text] [Related]
34. Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma.
Chen SA; Zhang JP; Wang N; Chen J
Technol Cancer Res Treat; 2023; 22():15330338231194555. PubMed ID: 38043946
[TBL] [Abstract][Full Text] [Related]
35. In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers.
Kim J
World J Surg Oncol; 2021 Jun; 19(1):188. PubMed ID: 34172056
[TBL] [Abstract][Full Text] [Related]
36. USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.
Yu Y; Chen G; Jiang C; Guo T; Tang H; Yuan Z; Wang Y; Tan X; Chen J; Zhang E; Wang X
J Gene Med; 2024 Jan; 26(1):e3594. PubMed ID: 37699648
[TBL] [Abstract][Full Text] [Related]
37. Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis.
Cai P; Zheng H; She J; Feng N; Zou H; Gu J; Yuan Y; Liu X; Liu Z; Bian J
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32210020
[TBL] [Abstract][Full Text] [Related]
38. Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis.
Wang A; Chen M; Wang H; Huang J; Bao Y; Gan X; Liu B; Lu X; Wang L
Biomed Res Int; 2019; 2019():2325765. PubMed ID: 31950034
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
Bai Y; Chen R; Sun J; Guo Y
Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
[TBL] [Abstract][Full Text] [Related]
40. Identification of biomarkers of renal ischemia-reperfusion injury by bioinformatics analysis and single-cell sequencing analysis combined with in vivo validation.
Zhu Q; Ren S; Sun Z; Qin J; Sheng X
Transpl Immunol; 2023 Dec; 81():101928. PubMed ID: 37704087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
